Skip to main content

Acute Inflammation

Acute Inflammation: 
def.
 lasts minutes to days and characterized by exudation of fluid and plasma proteins and emigration of leukocytes, predominantly neutrophils.
1. Alterations in vascular caliber that lead to increased blood flow: vasodilation
2. Microvascular structural changes that allow exudation of plasma protens and leukocytes: increased permeability mediated by histamine, bradykinin, leukotrienes, substance P, endothelial retraction
exudate (s.g. > 1.012) vs. transudate (s.g. < 1.012)
3. Emigration of leukocytes: margination, rolling, adhesion, diapedesis, migration
neutrophils predominate (6-24 hours) and replaced by monocytes (24-48 hours)
E-selectin (endothelium) - rolling, adhesion [induced by IL-1 and TNF]
P-selectin (endothelium, platelets) - rolling [present in Weibel-Palade bodies]
L-selectin (leukocytes) - homing
ICAM (interacts with integrins LFA-1 on leukocytes) - adhesion, arrest, transmigration
VCAM (interacts with integrins on eos, monos, lymphs) - adhesion
PECAM-1 (CD31) - platelet-endothelial cell adhesion molecule
Chemotaxis - C5a, LTB4, IL-8
4. Leukocyte activation
Production of arachidonic acid metabolites
Degranulation/Oxidative Burst
Modulation of leukocyte adhesion molecules
5. Phagocytosis
· Recognition and attachment via opsonization (Fc fragment of IgG, C3b, collectins)
· Engulfment via binding of the opsonized particle to the FcgR
· Killing or degradation via
- oxygen-dependent mechanisms using NADPH oxidase, myeloperoxidase (H2O2 + Cl- ®HOCl, destroys bacteria by halogenation)
- oxygen-independent mechanisms (bactericidal permeability increasing protein, lysozyme, lactoferrin, major basic protein, defensins)
After killing acid hydrolases in azurophil granules degrade bacteria within phagolysosomes
Leukocytes can also release products into the extracellular space (lysosomal enzymes, oxygen metabolites, arachadonic acid derivatives) during "regurgitation during feeding" (phagocytic vacuole open to outside transiently), "frustrated phagocytosis" (enzymes released but phagocytosis doesn't occur), "surface phagocytosis" (vacuoles are opened against a resistant surface) or exocytosis. After phagocytosis neutrophils may undergo Mac-1 mediated apoptosis.

One of Four Outcomes to Acute Inflammation:
1. Complete resolution
2. Abscess formation
3. Healing by connective tissue replacement (fibrosis)
4. Progression to chronic inflammation
Chemical Mediators of Inflammation
I.
 Vasoactive amines:
- Histamine (released by mast cell in respomse to physical injury, immune reactions, C3a, C5a, histamine-releasing protein, neuropeptides e.g. substance P, IL-1, IL-8)
- Serotonin (AKA 5-HT) released by platelets (on aggregation) and enterochromaffin cells
II. Plasma Proteases:
- Complement via classic (Ag-Ab mediated) or alternative (endotoxin-mediated) pathway ending in MAC (C5-C9) transmembrane attack complex
- C5a chemotactic factor - C3b and C3bi are opsonins
- controlled by protein inhibitors (C3 and C5 convertases, decay accelerating factor (DAF), factor I (cleaves C3b), C1 inhibitor, CD59)
III. Kinin System
Hageman factor (XII) binds to negatively charged surfaces:
Kininogens -(kallikreins)® kinins (vasoactive peptides) e.g. bradykinin
Kallikrein itself is a potent activatory of Hageman factor leading to autocatalytic activation
IV. Clotting System
Hageman factor (XII) stimulates intrinsic clotting cascade
Factor Xa is where intrinsic and extrinsic cascades converge (­vascular permeability and leukocyte exudation)
Final step is creation of thrombin; (fibrinopeptides also ­vascular permeability and leukocyte exudation)
V. Arachidonic Acid Metabolites
AA is a 20-carbon polyunsaturated fatty acid that occurs as a membrane phospholipid and is released by phospholipase A2
AA is converted by lipoxygenase to LTA4, LTB4, LTC4, LTD4, LTE4
· LTB4 - chomataxis, neutrophil activation and adhesion, neutrophil generation of O2 free radicals and lysosomal enzyne relaese
· LTC4, LTD4, LTE4 - vasoconstriction, bronchospasm, ­ vascular permeability
AA is converted by cyclooxygenase (mediated by COX1 and COX2 genes) to PGG2, PGH2, PGE2, PGD2, PGF2a, PGI2 (prostacyclin) and TXA2 (thromboxane)
· Prostaglandins - pain, fever, vasodilation
· Prostacyclin - vasodilator, platelet aggregation, potentiated permeability and chemotactic effects of other mediators
· Thromboxane - vasoconstrictor, platelet aggregation
Lipoxins are derived from AA via transcellular biosynthetic mechanisms (plt/neut interactions) - proinflammatory and anti-inflammatory actions: inhibit neutrophils but stimulate monocytes.
Aspirin and NSAIDS inhinit cyclooxygenase pathway (PG synthesis).
Glucocorticoids downregulate COX2.
Fish oil has linoleic acid and produces less potent leukotrienes (LTs).
VI. Platelet Activating Factor (PAF)
Derived from IgE-sensitized basophils.
Actions: plt aggregation, vasoconstriction, bronchoconstriction, ­ adhesion, chemotaxis, degranulation and ox burst, ­ synthesis of other mediators (eiconasoids)
VII. Cytokines and Chemokines
Effects are often redundant
Regulate lymphocytes: IL2, IL4, IL10, TGFb
Natural immunity: TNFa, IL1b, IFNa, IFNb, IL6
Activate inflammatory cells: IFNg, TNFa, TNFb, IL5, IL10, IL12
Hematopoiesis: IL3, IL7, c-kit ligand, GCSF, MCSF, GMCSF, stem cell factor
Control of acute phase response: TNFa and IL1
Chemokines: small proteins with paired cysteine residues and disulfide bonds
Function as activators & chemoattractants 
C-X-C or a chemokinesStimulate neutrophilsIL-8
C-C or b chemokinesAttract monos, eos, basos & lymphsMCP1, MIP1a, RANTES
C or g chemokinesLymphocytesLymphotactin
CX3C chemokinesMonos and T cellsFractalkine
VIII. Nitric Oxide
NO is a soluble gas which acts in a paracrine manner to induce cGMP in target cells
Produced by: endothelial cells, macrophages, neurons.
L arginine -(NO synthase, constitutive/induced)® NO
Actions: vasodilation, reduces platelet aggregation and adhesion, reduces leukocyte recruitment.
IX. Lysosomal Constituents of Leukocytes
Neutrophils have two majr types of granules:
azurophil (primary): larger, peroxidase-positive; MPO, lysozyme, defensins, acid hydrolase, neutral proteases (elastase, cathepsin G, proteinase 3, nonspec collagenases). Released into phagolysosome.
specific (secondary): smaller, peroxidase-negative - lysozyme, collagenase, gelatinase, lactoferrin, plasminogen activator, histaminase, alkaline phosphatase. Released extracellularly.
Acid proteases - degrade proteins at an acid pH within phagolysosome
Neutral proteases - degrade proteins extracellularly
Antiproteases - hold them in check, e.g. a1-antitrypsin (inhib neutrophil elastase), a2-macroglobulin 
X. Oxygen-Derived Free Radicals
Superoxide (O2·), Hydrogen peroxide (H2O2), Hydroxyl radical (OH·)
Extracellular release can increases expression of chemokines (IL8), cytokines and endothelial-leukocyte adhesion molecules.
Antioxidants: ceruloplasmin, transferrin, superoxide dismutase, catalase, glutathione peroxidase.
XI. Neuropeptides
Substance P: pain transmission, BP regulation, immune and endocrine cell secretion, increase vascular permeability
Neurokinin A


Defects in Leukocyte Function and Associated Diseases 
Defects in Leukocyte Adhesion

Leukocyte Adhesion Deficiency Type I
Clinical: Impaired leukocyte adhesion and recurrent bacterial infections
Pathophysiology: Defect in integrin b2 chain (shared by LFA-1 and Mac-1): CD18

Leukocyte Adhesion Deficiency Type II
Clinical: Impaired leukocyte adhesion and recurrent bacterial infections (milder than LAD1) 
Pathophysiology: Absence of sialyl-Lewis X, ligand for E-selectin, due to a defect in fucose metabolism 

Defects in Phagocytosis

Chediak-Higashi Syndrome

Defects in Microbicidal Activity
Chronic Granulomatous Disease


Chronic Inflammation: 
def.
 inflammation of prolonged duration (weeks or months) and associated histologically by lymphocytes and macrophages, proliferation of blood vessels, fibrosis and necrosis. Active inflammation, tissue destruction and repair proceeding simultaneously. Occurs in the following settings:
· Persistent infections
· Prolonged exposure to toxic agents (exogenous or endogenous)
· Autoimmunity 

Cells in Chronic Inflammation:
Monocytes: activated by cytokines (IFN-g) secreted by T lymphs, bacterial endotoxins and fibronectin; predominant cell type in 48 hrs. Life span of tissue macrophages is several months.
Lymphocytes, Plasma cells, Mast cells, 
Eosinophils: eotaxin stimulated CCR-3 receptor, granules contain major basic protein (MBP) a cationic protein which is toxic to parasites and epithelial cells.

Granulomatous Inflammation:

def. predominant cell type is the activated macrophage with epithelioid appearance.
Granuloma: def. a focal area of granulomatous inflammation. It consists of a microscopic aggregate of macrophages transformed into epithelium-like cells, surrounded by a collar of lymphocytes and plasma cells. May or may not include giant cells.
Examples: tuberculosis, leprosy, syphilis, cat-scratch disease, foreign-body reaction

Morphologic patterns in acute & chronic inflammation:
· Serous inflammation - marked by effusion (skin blister)
· Fibrinous inflammation - fibrinolysis leads to resolution; conversion to scar called organization.
· Supperative or purulent inflammation - neutrophils, necrotic cells and edema; usually caused by pyogenic bacteria (e.g. staphylococci). An abscess is a focal, localized collection of purulent inflammatory tissue.
· Ulcers - local defect of the surface of a tissue or organ caused by sloughing of inflammatory or necrotic tissue.

Systemic effects of inflammation
· Fever (coordinated by hypothalamus): IL-1, IL-6, TNFa, IFN
· Acute Phase Reaction:
- endocrine & metabolic: C-reactive protein (CRP), serum amyloid A (SAA), serum amyloid P (SAP), complement and coagulation proteins; CRP, SAA and SAP can act as opsonins and fix complement.
- autonomic and behavioral changes: peripheral vasoconstriction and deep vasodilation, rigors, chills, anorexia
· Leukocytosis: leukemoid reactions due to an accelerated release of cells from the bone marrow.
- neutrophilia: most bacterial infections
- lymphocytosis: mononucleosis, mumps, German measles
- eosinophilia: asthma, hay fever, parasitic infections
· Leukopenia: viruses, typhoid fever, rickettsiae, certain protozoa.

Comments

Popular posts from this blog

Effect of pH and Temperature

Effect of pH and Temperature on Oxygen Transport In addition to changes in P O 2 , the loading and unloading reac- tions are influenced by changes in the affinity (bond strength) of hemoglobin for oxygen. Such changes ensure that active skeletal muscles will receive more oxygen from the blood than they do at rest. This occurs as a result of the lowered pH and increased temperature in exercising muscles. The affinity is decreased when the pH is lowered and increased when the pH is raised; this is called the Bohr effect. When the affinity of hemoglobin for oxygen is reduced, there is slightly less loading of the blood with oxygen in the lungs but greater unloading of oxygen in the tissues. The net effect is that the tissues receive more oxygen when the blood pH is lowered (table 16.8). Since the pH can be decreased by carbon dioxide (through the formation of carbonic acid), the Bohr effect helps to provide more oxygen to the tissue...

Pathophysiology of heart failure

Pathophysiology of heart failure In heart failure, the heart may not provide tissues with adequate blood for metabolic needs, and cardiac-related elevation of pulmonary or systemic venous pressures may result in organ congestion. This condition can result from abnormalities of systolic or diastolic function or, commonly, both. Although a primary abnormality can be a change in cardiomyocyte function, there are also changes in collagen turnover of the extracellular matrix. Cardiac structural defects (eg, congenital defects, valvular disorders), rhythm abnormalities (including persistently high heart rate), and high metabolic demands (eg, due to thyrotoxicosis) also can cause HF.

Frank-Starling Law of the Heart

Frank-Starling Law of the Heart Two physiologists, Otto Frank and Ernest Starling, demonstrated that the strength of ventricular contraction varies directly with the end-diastolic volume (fig. 14.2). Even in experiments where the heart is removed from the body (and is thus not subject to neural or hormonal regulation) and where the still-beating heart is filled with blood flowing from a reservoir, an increase in EDV within the physiological range results in increased contraction strength and, therefore, in increased stroke volume. This rela- tionship between EDV, contraction strength, and stroke volume is thus a built-in, or intrinsic, property of heart muscle, and is known as the Frank-Starling law of the heart.